In Vitro Diagnostics (IVD) plays a crucial role in life-saving clinical decisions. To recognize and thank the healthcare professionals and laboratory teams who make this possible every day, Werfen has launched the ‘Thank You’ initiative.

Launched on the occasion of its 60th anniversary, this is the company's first corporate brand campaign centered entirely on its purpose of advancing patient care by delivering trusted and innovative specialized diagnostics.  

Currently, IVD influences around 70% of clinical decisions worldwide, ranging from confirming compatibility in a kidney transplant to detecting chronic disease or monitoring patients during highly complex cardiac surgery. However, this analytical work largely takes place behind the scenes. 

The central element in the campaign is a documentary short film, available at https://www.werfen.com/thankyou/. With it, Werfen seeks to highlight the direct impact of having reliable and timely data, at the time of diagnosis and in the continuous management of diseases and people's quality of life, focusing on improving patient outcomes through diagnostic precision. 

The campaign gathers stories from real patients who have gone through complex health processes. Through their stories, patients express their gratitude to the healthcare professionals who interpreted their test results and provided the necessary clarity to determine the appropriate therapeutic path to manage their health.  

Developed in collaboration with patient associations and non-profit organizations, the initiative gives visibility to the relevance of diagnostics in more than a dozen pathologies such as lupus, thalassemia, hemophilia, thrombosis episodes, rheumatoid arthritis, complex cardiac surgery, or kidney and liver transplants. All of them are severe medical conditions that represent Werfen's five highly specialized clinical areas: Hemostasis, Acute Care Diagnostics, Transfusion, Autoimmunity, and Transplant.  

Visit Werfen for more information